AAMI joins with gov't, pharmacists in call for infusion intel
Do you work with smart drug pumps? Can you provide examples of policies and procedures related to drug-library management? How about checklists or descriptions of procedures related to maintaining and updating such libraries?
If you answered 'Yes' to the first question and either of the other two, the Association for the Advancement of Medical Instrumentation (AAMI), the American Society of Healthcare Pharmacists (ASHP) and the FDA all want to hear from you.
AAMI announced in an Aug. 30 statement that its Drug Library Management: Device Issues Working Group is partnering with ASHP and the FDA to reach out to the healthcare community “in a collaborative effort to develop guidelines and recommendations for the management of smart pump drug libraries.” To those ends, the partnership needs input and documents from healthcare professionals.
The request for participation from healthcare workers comes in the wake of a 2010 AAMI-FDA summit on the safety of infusion pumps. The discussion produced an action plan to address the mushrooming incidence of infusion-pump problems. Some 56,000 of these were reported to FDA between 2005 and 2009.
The AAMI statement assures contributors that all information submitted “will be kept strictly confidential, and will be used for the sole purpose of helping the working group to develop guidance documents and recommendations.”
To contribute information, email Deborah Reuter at dreuter@aami.org.
If you answered 'Yes' to the first question and either of the other two, the Association for the Advancement of Medical Instrumentation (AAMI), the American Society of Healthcare Pharmacists (ASHP) and the FDA all want to hear from you.
AAMI announced in an Aug. 30 statement that its Drug Library Management: Device Issues Working Group is partnering with ASHP and the FDA to reach out to the healthcare community “in a collaborative effort to develop guidelines and recommendations for the management of smart pump drug libraries.” To those ends, the partnership needs input and documents from healthcare professionals.
The request for participation from healthcare workers comes in the wake of a 2010 AAMI-FDA summit on the safety of infusion pumps. The discussion produced an action plan to address the mushrooming incidence of infusion-pump problems. Some 56,000 of these were reported to FDA between 2005 and 2009.
The AAMI statement assures contributors that all information submitted “will be kept strictly confidential, and will be used for the sole purpose of helping the working group to develop guidance documents and recommendations.”
To contribute information, email Deborah Reuter at dreuter@aami.org.
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.